LM-364 alone or with other therapy for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This study tests a new experimental drug, LM-364, given alone or with other cancer treatments for people with advanced solid tumors. It aims to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are able to do light work or be fully active (ECOG score 0 or 1)
- You have not had another cancer treatment or trial in the last 28 days
- You do not have a history of autoimmune disease or serious heart problems
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called LM-350 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth.
This Phase I/II study tests LM-101, a new injection, in adults with advanced solid cancers that have already been treated and kept growing. It aims to see how safe it is and whether it can shrink tumors or help people live longer.
This study tests a new drug called LM-299 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if LM-299 is safe and effective.
This study tests a new drug called LM-168, either alone or with another immunotherapy (toripalimab), in people with advanced solid tumors that haven't responded to standard treatments. It aims to see if this combination is safe and effective, and may offer a new option when others have stopped working.
This trial tests a new drug, ML-016, for people with advanced solid tumors that have spread to the lungs or liver and haven't responded to standard treatments. It aims to see if the drug can help shrink tumors or stop them from growing.
This trial tests a new drug called LM-168, either alone or combined with another cancer treatment, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.